Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2022-02-28
2023-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Stage Retinal Abnormalities in Type 1 Diabetes, Screened With OCT Angiography.
NCT03496597
Biomarker of Diabetic Retinopathy
NCT05079399
AI Screening for Diabetic Retinopathy
NCT05704491
Incidence of Retinopathy and Associated Risk Factors in Children and Young Adults With Type 1 Diabetes in Denmark
NCT01785667
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control
NCT01323348
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
People with type 2 diabetes
People diagnosed with type 2 diabetes age 18-70
Diabetic Retinopathy Screening
Screenings are performed in the diabetes consultation in general practice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diabetic Retinopathy Screening
Screenings are performed in the diabetes consultation in general practice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understands Danish
* Age between 18-70
Exclusion Criteria
* Cannot partake in second screening
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Malene Krogh
Ph.D. student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malene Krogh
Role: PRINCIPAL_INVESTIGATOR
Aalborg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Malene Krogh
Aalborg, DK, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
mKrogh
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.